Text Message Outreach Can Help Increase Mammogram Completion Rates
By Elana Gotkine HealthDay Reporter
MONDAY, May 6, 2024 -- Text messaging women after initial outreach for breast cancer screening increases mammogram completion rates, according to a study published online May 6 in JAMA Internal Medicine.
Shivan J. Mehta, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted two concurrent trials involving women aged 40 to 74 years with at least one primary care visit in the past two years. In trial A, women were randomly assigned to receive a signed bulk order for a mammogram or no order; patients were concurrently assigned to receive or not receive text message reminders. In trial B, women were randomly assigned to receive a message signed by their primary care clinician (clinician endorsement) or from the organization (standard messaging) and were concurrently assigned to receive or not receive text message reminders.
A total of 24,632 women were included in the trials. The researchers found that at three months, there was a significant increase in the percent of patients completing a mammogram in the bulk order arm (15.4 versus 12.7 percent) in trial A. There was also a significant increase in mammogram completion in the text messaging arm (15.1 versus 13.0 percent). At three months in trial B, mammogram completion was not significantly different in the clinician endorsement versus standard messaging arm (12.5 and 11.4 percent, respectively). A significant difference was seen in the text-messaging arm versus no text-messaging arm (13.2 versus 10.7 percent).
"Large-scale campaigns can be enhanced using new insights from behavioral science and information technology," the authors write.
One author disclosed financial ties to Guardant Health.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Donepezil Not Beneficial for Cognitive Impairment in Breast Cancer Survivors
FRIDAY, May 24, 2024 -- A once-daily dose of donepezil does not improve cognitive function among breast cancer survivors exposed to chemotherapy one to five years earlier...
ASCO: Survivors of Early Breast Cancer Can Successfully Attempt Pregnancy
THURSDAY, May 23, 2024 -- Most survivors of stage 0 to III breast cancer who attempt pregnancy postdiagnosis are able to become pregnant and have a live birth, according to a...
4-Dimensional Model Can Predict Lymph Node Metastases in Breast Cancer
THURSDAY, May 23, 2024 -- A deep learning model using tumor dynamic contrast-enhanced breast magnetic resonance imaging (MRI) has high sensitivity for identifying lymph node...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.